Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1385020-40-5 Chemical Structure| 1385020-40-5

Structure of Filanesib HCl
CAS No.: 1385020-40-5

Chemical Structure| 1385020-40-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Filanesib hydrochloride is a Kinesin spindle protein (KSP) inhibitor that disrupts cell division. It shows significant anti-proliferative activity in cancer treatment.

Synonyms: ARRY-520 hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Filanesib HCl

CAS No. :1385020-40-5
Formula : C20H23ClF2N4O2S
M.W : 456.94
SMILES Code : O=C(N1[C@@](C2=CC=CC=C2)(CCCN)SC(C3=CC(F)=CC=C3F)=N1)N(OC)C.[H]Cl
Synonyms :
ARRY-520 hydrochloride
MDL No. :MFCD30747801

Safety of Filanesib HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Related Pathways of Filanesib HCl

RTK
cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HUH6 10 nM 72 hours Evaluate the effect of Filanesib on HUH6 cell viability; 10 nM Filanesib reduced cell viability by approximately 40% NPJ Precis Oncol. 2025 Apr 25;9(1):122
HB-279 1 nM 72 hours Evaluate the effect of Filanesib on HB-279 cell viability; 1 nM Filanesib reduced ATP concentration by 80% NPJ Precis Oncol. 2025 Apr 25;9(1):122
HB-303 10 nM 72 hours Evaluate the effect of Filanesib on HB-303 cell viability; Filanesib was effective in all models, reducing ATP concentration by at least 30% NPJ Precis Oncol. 2025 Apr 25;9(1):122

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice HB PDX models Oral gavage 20 mg/kg Every 4th day for 18 days Evaluate the in vivo effect of Filanesib on HB tumor growth; Filanesib reduced the rate of tumor growth in 4/5 HB PDX models, with HB-279 showing complete growth arrest NPJ Precis Oncol. 2025 Apr 25;9(1):122
CB17-SCID mice Subcutaneous plasmacytoma model Intraperitoneal injection 10 mg/kg Filanesib 2 days per week, pomalidomide 5 days per week, dexamethasone 2 days per week, continuous treatment Evaluate the antimyeloma activity of the triple combination of filanesib with pomalidomide and dexamethasone, showing significant tumor growth delay and improved survival in mice Haematologica. 2017 Dec;102(12):2113-2124

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.94mL

2.19mL

1.09mL

21.88mL

4.38mL

2.19mL

 

Historical Records

Categories